Intervention Review

Rivastigmine for dementia in people with Down syndrome

  1. Monica Mohan1,*,
  2. Cathy Bennett2,
  3. Peter K Carpenter3

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 30 OCT 2008

DOI: 10.1002/14651858.CD007658


How to Cite

Mohan M, Bennett C, Carpenter PK. Rivastigmine for dementia in people with Down syndrome. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD007658. DOI: 10.1002/14651858.CD007658.

Author Information

  1. 1

    The Burden Centre, Department of Neuropsychiatry, Neuropsychology and Epileptology, Bristol, Avon, UK

  2. 2

    Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK

  3. 3

    Litfield House Medical Centre, Bristol, UK

*Monica Mohan, Department of Neuropsychiatry, Neuropsychology and Epileptology, The Burden Centre, The North Bristol Trust, Frenchay Hospital, Bristol, Avon, BS16 1JB, UK. drmonicamohan@yahoo.co.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Angelo Carfì, Manuela Antocicco, Vincenzo Brandi, Camilla Cipriani, Francesca Fiore, Donatella Mascia, Silvana Settanni, Davide L. Vetrano, Roberto Bernabei, Graziano Onder, Characteristics of Adults with Down Syndrome: Prevalence of Age-Related Conditions, Frontiers in Medicine, 2014, 1,

    CrossRef

  2. 2
    Vee Prasher, Anthony Fernando, Pharmacological treatment of dementia in people with learning disabilities, Advances in Mental Health and Learning Disabilities, 2009, 3, 3, 10

    CrossRef